Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. - Wikidata - awgldk - TriplyDB

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

http://www.wikidata.org/entity/Q35018048

about

Interferon-alpha, immune activation and immune dysfunction in treated HIV infection Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline Disease-promoting effects of type I interferons in viral, bacterial, and coinfections Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation A Computational Model of Inhibition of HIV-1 by Interferon-Alpha The role of type I interferons in intestinal infection, homeostasis, and inflammation.Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion.HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.Identification of miRNA-mRNA crosstalk in CD4+ T cells during HIV-1 infection by integrating transcriptome analyses.HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection.Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir.Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.Bystander chronic infection negatively impacts development of CD8(+) T cell memory.T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection.Morphine-potentiated cognitive deficits correlate to suppressed hippocampal iNOS RNA expression and an absent type 1 interferon response in LP-BM5 murine AIDS.Short-term pIFN-α2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure.Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals

P2860

Q26861003-B8A7BC32-179D-4EC6-A280-AC4E4BF04E58 Q27342233-611EC3BB-1B1F-4384-8A87-18F59D44F965 Q28082841-957A5F7A-4521-4927-B690-200D26E9AF19 Q34059183-D842B263-B551-480B-9312-4B7094AA35F1 Q34106393-432A6FDF-BDA5-4920-B835-6BBA40973E7C Q35564886-5B274E81-4A4E-4BB8-BAB1-692A46E455C0 Q35627713-2075BB08-FC1A-4EE7-AA86-D9FFFF5FEB74 Q35864559-4492FA81-F5EA-433E-A930-ABE71A91FDDF Q35969164-575AB942-2675-44C5-8CA4-CB84AA17E484 Q36001052-C92E9D66-4F52-4ED3-BC3D-D3C4892E4654 Q36106065-63EA8A74-F0A5-4144-8B1A-0E49A460EDF5 Q36770954-E9F1D44C-E264-4657-A741-587CD836ED83 Q36777093-45E0632F-D748-43BD-B0D9-71F9DAF879E3 Q37642643-5B5831E9-849A-4C8F-BCF5-1D305574D829 Q37655340-87DDF741-A446-4CA2-B49B-B02DCB47E18D Q38816188-69104D93-FB8A-414D-9817-0904CFBEE5CB Q40056964-FC7B83FD-0ACE-467B-A154-F76F11D9659C Q40160105-BB81D93D-2224-4E73-8683-893234284F76 Q40395105-8ADFE376-B74A-434D-A34E-28FB0AB3DF80 Q40669752-BB4B87A8-D75A-4C92-BA52-9C4DD5ACF5B9 Q40705563-1CAB4177-86E1-48CB-B464-0557E9BA5F8B Q41809254-9646F677-7065-40B2-B86B-1F4D44294294 Q42061089-8640F9F1-1DC2-419F-BCD8-F141EB3830F4 Q47558114-16376885-025D-4822-82EF-E7AB03B74AC9 Q52653905-F8E4BA7E-3F6E-4B24-9CC9-7A078DD6085C Q52662103-028A9CFD-2F4A-48C7-8257-C793DC4C0B51 Q54222562-49539F4E-8FE8-4F84-AE2C-880931FF8FC2 Q54253587-EDD68560-B64F-4909-8AD3-C3C21548662C Q55153874-862649D9-C11B-47FA-B461-A00A9CECA40D Q57292398-078FB741-DF16-46FD-BE27-AFDB33F5341F

P2860

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

http://www.wikidata.org/entity/Q35018048

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Type I interferon upregulates ...... iciency virus (HIV) infection.

@ast

Type I interferon upregulates ...... iciency virus (HIV) infection.

@en

type

label

Type I interferon upregulates ...... iciency virus (HIV) infection.

@ast

Type I interferon upregulates ...... iciency virus (HIV) infection.

@en

prefLabel

Type I interferon upregulates ...... iciency virus (HIV) infection.

@ast

Type I interferon upregulates ...... iciency virus (HIV) infection.

@en

P1433

Q35018048-FE273451-5816-4FAB-B1BD-7AF612D9DFE5

P1476

Q35018048-06EE028F-4B4B-4020-8A8C-9F0B6213A74C

P2093

Q35018048-206CF3D1-7F62-4F39-B703-35CB0EBC65C7

Q35018048-20874646-9838-4AAD-B956-EA53D4FB85B6

Q35018048-4023D705-7035-471E-BE58-043D26028690

Q35018048-4BCC21FE-CD89-4ACD-911A-1F9386349F23

Q35018048-6BE12A2C-4937-46BD-8531-BA40BDBEB026

Q35018048-8AC718B3-556C-4A92-B9BF-6E669AE14818

Q35018048-ABD755E7-5C5F-4B12-A6FC-DE72A238EEBE

Q35018048-CA26ED3D-FC37-4F5D-81F6-8018304AFD6B

P2860

Q35018048-04D507C0-29C2-43F9-A61D-E1FDC814CB75

Q35018048-09ED4419-6BED-47E6-94CA-6646BBEC57E6

Q35018048-0B0F1A30-1F9C-40A0-A404-EFF1080529B4

Q35018048-15342CE5-CC60-4154-B092-CB467810BB22

Q35018048-1AC1EF68-E757-4E6D-A927-A1BFC80962B6

Q35018048-235BE3E9-D67B-4FA2-BC26-7221F16EFB89

Q35018048-2487F3A0-E9A7-43E8-AF90-33E076B94921

Q35018048-2A16E5D7-480F-49B4-B06A-05F5AC2F4792

Q35018048-2EAD9815-DD75-49D8-88DF-2AFDF9D03155

Q35018048-32158CFC-60C9-4561-BAEC-B46BB5577694

P304

Q35018048-4618FB86-F480-4D1A-80FA-9EBF886D86ED

P31

Q35018048-485BCB45-82E5-42B8-9082-0FB05FE4A657

P356

Q35018048-435ED41D-711E-4F5D-A14F-D8EB24268A1E

P433

Q35018048-117401F2-B002-4885-AC60-92EC8B12EF24

P478

Q35018048-1F00717F-11FC-43A0-992E-2D8B9E971BB1

P50

Q35018048-03CA2B04-ED61-4094-8324-820E423DA23C

Q35018048-7BD2D667-AF83-4559-963E-DAD0F4B9F84C

Q35018048-990E364D-4C6C-4F47-9555-8AD3919F7361

Q35018048-B2A291A7-3C7D-4DA8-9CA2-E4869D659C31

Q35018048-E99DAF4C-01C7-41C3-B221-7A8C3ED3C744

P577

Q35018048-7542D27F-AA07-4E4E-ABEB-0540395A430F

P5875

Q35018048-B3181275-586D-44F3-92D7-6F509DE14C9C

P698

Q35018048-FD96CA07-00AC-4419-A104-02459A30FDDA

P932

Q35018048-34B4B7E1-41B6-4C49-96D8-FC02D346AD3B

P356

JOURNAL.PPAT.1003658

P1433

P1476

Type I interferon upregulates ...... iciency virus (HIV) infection.

@en

P2093

Alina C Boesteanu

http://www.w3.org/2001/XMLSchema#string

Duc H Do

http://www.w3.org/2001/XMLSchema#string

Guibin Yang

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Jacobson

http://www.w3.org/2001/XMLSchema#string

Joseph A Fraietta

http://www.w3.org/2001/XMLSchema#string

Luis D Giavedoni

http://www.w3.org/2001/XMLSchema#string

Noshin Kathuria

http://www.w3.org/2001/XMLSchema#string

Shannon E McGettigan

http://www.w3.org/2001/XMLSchema#string

P2860

tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

Inhibition of death receptor signals by cellular FLIP

Regulation of CD95/Fas signaling at the DISC

Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.

Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication.

Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes

P304

e1003658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1003658

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Peter D Katsikis

Jennifer L Hope

Donald T Gracias

Yvonne M Mueller

P577

2013-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257839777

http://www.w3.org/2001/XMLSchema#string

P698

24130482

http://www.w3.org/2001/XMLSchema#string

P932

3795023

http://www.w3.org/2001/XMLSchema#string